NCT01822249View on ClinicalTrials.gov

Phase 2 Study of EPI-743 for Treatment of Rett Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Rett Syndrome
Interventions
DRUG

EPI-743

DRUG

Placebo

Trial Locations (1)

Unknown

University of Siena, Siena

Sponsors
All Listed Sponsors
lead

Edison Pharmaceuticals Inc

INDUSTRY